ArticleFrontiers in endocrinology2025
Development and validation of an explainable machine learning and nomogram model for early detection and risk stratification of polycystic ovary syndrome: a multicenter study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Machine learning and deep learning for diagnosis of Polyendocrine Metabolic Ovarian Syndrome: systematic review and meta-analysis.Frontiers in endocrinology · 2026Pooled it
- From explainability to clinical actionability: translating artificial intelligence models into decision support for endocrine disease management.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Polycystic ovary syndrome (PCOS) is a common endocrine-metabolic condition in reproductive-aged women, linked to infertility and long-term cardiometabolic risk. Early identification remains challenging because current diagnosis relies on hormone testing and imaging. This research sought to develop and evaluate an interpretable machine learning (ML) model and a simplified nomogram for the early detection of PCOS. Methods: Data from 1,600 women at the First People's Hospital of Jiashan were used for model training, with 283 external cases from Jiaxing Hospital of Traditional Chinese Medicine for validation. Twenty-three routine laboratory indicators were analyzed. After LASSO feature selection, seven ML algorithms were compared. The best-performing XGBoost model was interpreted using Shapley Additive exPlanations (SHAP). A logistic regression-based nomogram was developed from the key predictors. Results: The XGBoost model showed excellent discrimination (AUC = 0.919 internal; 0.923 external). SHAP identified DHEAS, AMH, TG, and age as key contributors. The nomogram also performed well (AUC = 0.901 train; 0.887 test). Conclusions: This interpretable "XGBoost + SHAP" and nomogram framework provides an accurate, transparent, and practical tool for early PCOS screening and individualized management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.